CATX Perspective Therapeutics, Inc.

NEUTRAL Impact: 3/10 PRESS-RELEASE
Horizon days Filed Apr 24, 2026 Processed 1mo ago Wire GlobeNewswire
Press release: announcement
Latest settled — T+20d
CATX ▼ -14.19% at T+20d
NEUTRAL call ✗ call lost -14.19% · α vs SPY -18.22% · entry $4.51 → $3.87
Next anchor: T+60d in 5w
Last close $2.95 (close Jun 12) · -34.59% from $4.51 entry
Entry anchored
Apr 23, 03:59 PM ET
via Databento tick
T+1d
-5.32%
call -5.32% · α -5.49%
$4.27
settled 7w ago
T+5d
-13.53%
call -13.53% · α -14.43%
$3.90
settled 6w ago
T+20d
-14.19%
call -14.19% · α -18.22%
$3.87
settled 24d ago
T+60d
call — · α —
in 5w

Price Chart

Loading chart...

Executive Summary

Perspective Therapeutics announced upcoming corporate updates in May 2026, including an analyst event, first-quarter financial results press release, and participation in two healthcare conferences. No financial results or material operational updates were released at this time.

Actionable Insight

Traders should monitor the May 11 release of first-quarter financial results for material updates on cash burn, trial progress, or guidance. The May 4 analyst event may provide strategic clarity ahead of data readouts.

Key Facts

  • Company will host an analyst event on May 4, 2026, covering strategy, technology, and pipeline.
  • First Quarter 2026 Financial Results to be released via press release only on May 11, 2026, after market close.
  • Company to participate in BofA Securities and RBC Capital Markets healthcare conferences on May 13 and May 19, 2026, respectively.
  • No financial data or material developments were disclosed in this announcement.

Financial Impact

No immediate financial impact — this is a scheduling announcement only.

Risk Factors

  • Forward-looking statements are subject to risks including clinical trial delays, funding shortfalls, and regulatory uncertainty.
  • Failure to meet upcoming clinical or operational milestones could negatively impact investor sentiment.

Market Snapshot

Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
90% bullish (20 analysts)

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3280654
13 reports for CATX
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for CATX — sortable, filterable
Type Now
Jun 12, 2026
3d ago
Institutional Cluster
BULLISH ★ 5/10
$2.96 awaiting T+1awaiting T+1$2.95 (−0.34%)
Jun 11, 2026
3d ago
Institutional Cluster
NEUTRAL ★ 4/10
$2.96 awaiting T+1awaiting T+1$2.95 (−0.17%)
Jun 3, 2026
11d ago
Press Release
NEUTRAL ★ 5/10
$3.56 $3.25▼ −8.71%▼ −9.11%$2.95 (−17.13%)
Jun 1, 2026
13d ago
8-K
NEUTRAL ★ 3/10
$3.66 $3.60▼ −1.64%▼ −1.78%$2.95 (−19.40%)
May 21, 2026
24d ago
Press Release
NEUTRAL ★ 4/10
$3.98 $4.16▲ +4.52%▲ +3.94%$2.95 (−25.88%)
May 18, 2026
27d ago
Press Release
NEUTRAL ★ 3/10
$3.76 $3.63▼ −3.46%▼ −2.81%$2.95 (−21.54%)
May 11, 2026
4w ago
8-K
NEUTRAL ★ 4/10
$3.77 $3.77· 0.00%▼ −0.54%$2.95 (−21.75%)
May 4, 2026
5w ago
8-K
NEUTRAL ★ 2/10
$3.65 $3.82▲ +4.66%▲ +3.27%$2.95 (−19.18%)
Apr 24, 2026
7w ago
Press Release
NEUTRAL ★ 3/10
$4.51 $4.27▼ −5.32%▼ −5.49%$2.95 (−34.59%)
Apr 20, 2026
7w ago
Press Release
BULLISH ★ 7/10
$4.55 $4.64▲ +1.98%▲ +2.63%$2.95 (−35.16%)
Showing 10 of 13

US Market Status

Market Closed — Opens in 5h 4m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access